Nasdaq: APRE
Aprea Therapeutics insiders
The officers, directors and 10% owners of Aprea Therapeutics, Inc. who hold the most stock, valued at the live APRE price.
$0.49
APRE today +$28K (+6.07%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their APRE stock
- $2K
Insiders by value of APRE holdings
SEC ownership page| # | Insider | Role | Shares | Value | Overall rank |
|---|---|---|---|---|---|
| 1 | Jean-Pierre Bizzari | Director | 4,180 | $2K | 12191st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Aprea Therapeutics; see each profile for the filing.